MicroRNA Expression in Alzheimer Blood Mononuclear Cells

Various coding genes representing multiple functional categories are downregulated in blood mononuclear cells (BMC) of patients with sporadic Alzheimer disease (AD). Noncoding microRNAs (miRNA) regulate gene expression by degrading messages or inhibiting translation. Using BMC as a paradigm for the study of systemic alterations in AD, we investigated whether peripheral miRNA expression is altered in this condition. MicroRNA levels were assessed using the microRNA microarray (MMChip) containing 462 human miRNA, and the results validated by real time PCR. Sixteen AD patients and sixteen normal elderly controls (NEC) were matched for ethnicity, age, gender and education. The expression of several BMC miRNAs was found to increase in AD relative to NEC levels, and may differ between AD subjects bearing one or two APOE4 alleles. As compared to NEC, miRNAs significantly upregulated in AD subjects and confirmed by qPCR were miR-34a and 181b. Predicted target genes downregulated in Alzheimer BMC that correlated with the upregulated miRNAs were largely represented in the functional categories of Transcription/Translation and Synaptic Activity. Several miRNAs targeting the same genes were within the functional category of Injury response/Redox homeostasis. Taken together, induction of microRNA expression in BMC may contribute to the aberrant systemic decline in mRNA levels in sporadic AD.

[1]  W. Markesbery,et al.  DNA oxidation in Alzheimer's disease. , 2006, Antioxidants & redox signaling.

[2]  M. Gladwin,et al.  Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. , 2004, Blood.

[3]  J. Castle,et al.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs , 2005, Nature.

[4]  P. Provost,et al.  MicroRNAs in Gene Regulation: When the Smallest Governs It All , 2006, Journal of biomedicine & biotechnology.

[5]  G. Pasinetti,et al.  Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia , 2001, Journal of neuroscience research.

[6]  G. Ruvkun,et al.  The 20 years it took to recognize the importance of tiny RNAs , 2004, Cell.

[7]  George D. Mellick,et al.  Parkinson's Disease in Relation to Pesticide Exposure and Nuclear Encoded Mitochondrial Complex I Gene Variants , 2006, Journal of biomedicine & biotechnology.

[8]  V. Ambros,et al.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.

[9]  Oliver Hobert,et al.  Perfect seed pairing is not a generally reliable predictor for miRNA-target interactions , 2006, Nature Structural &Molecular Biology.

[10]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[11]  N. Bonini,et al.  MicroRNA pathways modulate polyglutamine-induced neurodegeneration. , 2006, Molecular cell.

[12]  J Carter,et al.  Molecular Pathology of Alzheimer's Disease , 2013 .

[13]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[14]  M. Kamboh.  Molecular Genetics of Late‐Onset Alzheimer's Disease , 2004, Annals of human genetics.

[15]  V. Ambros.  The functions of animal microRNAs , 2004, Nature.

[16]  E. Wang,et al.  Blood-sample processing for the study of age-dependent gene expression in peripheral blood mononuclear cells. , 2002, The journals of gerontology. Series A, Biological sciences and medical sciences.

[17]  Quaid Morris,et al.  Probing microRNAs with microarrays: tissue specificity and functional inference. , 2004, RNA.

[18]  K. Gunsalus,et al.  Combinatorial microRNA target predictions , 2005, Nature Genetics.

[19]  J. Messing,et al.  CARPEL FACTORY, a Dicer Homolog, and HEN1, a Novel Protein, Act in microRNA Metabolism in Arabidopsis thaliana , 2002, Current Biology.

[20]  N. Rajewsky,et al.  Cell-type-specific signatures of microRNAs on target mRNA expression. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[21]  H. Lipkin.  Where is the ?c? , 1978 .

[22]  J. Keller.  Interplay Between Oxidative Damage, Protein Synthesis, and Protein Degradation in Alzheimer's Disease , 2006, Journal of biomedicine & biotechnology.

[23]  Kaj Blennow,et al.  Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease. , 2003, Brain research. Molecular brain research.

[24]  H. Feldman,et al.  Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging. , 2004, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[25]  Hyman M. Schipper,et al.  Transcriptional profiling of Alzheimer blood mononuclear cells by microarray , 2007, Neurobiology of Aging.

[26]  W. Lukiw,et al.  Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus , 2007, Neuroreport.

[27]  C. Lin,et al.  Quantification of oxidized RNAs in Alzheimer's disease , 2006, Neurobiology of Aging.

[28]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[29]  N. Bonini,et al.  A New Role for MicroRNA Pathways: Modulation of Degeneration Induced by Pathogenic Human Disease Proteins , 2006, Cell cycle.

[30]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[31]  S. Gauthier,et al.  Assessment of Suspected Dementia , 2001, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[32]  E. Wang,et al.  Designer microarrays: from soup to nuts. , 2002, The journals of gerontology. Series A, Biological sciences and medical sciences.

[33]  Dana Ridzon,et al.  Nonrestrictive developmental regulation of microRNA gene expression , 2006, Mammalian Genome.

[34]  A. Levey,et al.  Loss of apolipoprotein E receptor LR11 in Alzheimer disease. , 2004, Archives of neurology.

[35]  H. Feldman,et al.  Apolipoprotein E ε4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging , 2004, Canadian Medical Association Journal.

[36]  S. Hammond.  RNAi, microRNAs, and human disease , 2006, Cancer Chemotherapy and Pharmacology.

[37]  F. Slack,et al.  A Developmental Timing MicroRNA and Its Target Regulate Life Span in C. elegans , 2005, Science.